China Life Insurance

China Life Insurance (Group) Company, headquartered in Beijing, is the largest commercial insurance group in Mainland China and the only state-owned insurance entity with assets exceeding 1 trillion RMB. Established in 1949 and restructured in 2003, China Life offers a comprehensive range of services including individual and group life insurance, accident and health insurance, pension plans, and asset management. The company commands approximately 20% of the life insurance market share in China, with life premium income significantly contributing to its revenue. It operates through various subsidiaries, which include China Life Insurance Company Limited and China Life Asset Management Company Limited, while also being a major institutional investor in China's capital markets. China Life is actively focusing on developing a senior-care ecosystem and enhancing its agent team to ensure sustainable long-term growth.

Wan Feng

Vice President

Xuanlai He

Executive Director, Fixed Income Portfolio Manager

Liu Huimin

Vice President

Miao Jianmin

Vice Chairman, President, Director

Cui Lanqin

Vice President

Zhang Xiangxian

Vice President

Yang Mingsheng

Chairman

H.C. Tung

Founder

16 past transactions

COFCO Fortune

Private Equity Round in 2023
COFCO Fortune provides high-quality food to customers through a fully integrated value chain with many well-known retailers and other state-owned enterprises.

Hanbon Sci.& Tech

Series C in 2022
Hanbon is a developer of chromatographic products for the biomedical industry. The company provides liquid chromatography products for laboratory analysis, small-scale tests, and pilot test scale-up. Hanbon offers various chromatography products such as analytical liquid chromatography and bio-lab laboratory chromatography systems.

Saint Bella

Series C in 2022
Santa Bella Maternal and Child Care Center is designed for pregnant mothers who are looking for a better life and have spiritual needs. Santa Bella allows every woman to become a better version of herself from the inside out in the 28 days following childbirth. Santa Bella is not only a nursing home but also a place for mothers and babies to begin living a luxurious lifestyle.

METiS Pharmaceuticals

Series A in 2021
Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and drug discovery. It combines advanced technologies like artificial intelligence, machine learning, and quantum simulation to achieve more effective design of innovative delivery materials, drug candidate selection and formulation design, "programmable nucleic acid drug" development, and nucleic acid delivery design.

METiS Therapeutics

Series A in 2021
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Valgen Medtech

Series B in 2021
Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.

Xinyi Energy

Post in 2020
Xinyi Energy is a solar farm operator in the PRC, mainly generates revenue from solar power electricity generation and sales of electricity to local subsidiaries of the State Grid, as well as receives management fees through the provision of operating and managing services of solar farms. All utility-scale solar farm projects owned by the Group are located in provinces with strong demand of electricity, such as Anhui Province, Hubei Province, Henan Province, Fujian Province and Tianjin Municipality, with no power curtailment problem ever in the past operating period. Currently, Xinyi Energy is owning a total of 16 solar farm projects with the aggregate approved capacity of 1,514 MW. Xinyi Energy intends to maintain a high dividend payout ratio. It's the Board's intention to declare and distribute not less than 90% of the distributable income for each financial year.

Vazyme Biotech

Series C in 2020
Vazyme Biotech is devoted to the development and production of enzymes and antibodies. Our products cover clinical diagnosis, molecular diagnostics, high-throughput sequencing and life science research and other related fields. The company is located in the city of Nanjing, china's ancient capital of the Six Dynasties. Vazyme Biotech is in the front of scenic Qixia mountain, dependent on the regional radiation force of the National Economic and Technological Development Zone of Nanjing. With advanced capability of R&D and cutting- edge technology, Vazyme Biotech will create a new pattern of National Biotechnology.

Jusda

Series A in 2019
JUSDA, a service platform of supply chain management for Foxconn Technology Group and a pilot in integrating C2C (Component to Consumer) supply chain services around the world, is committed to driving professionalism and growth of supply chain management by advanced technology and R&D. The company applies an innovative business model that covers trading flow, goods flow, information flow, capital flow, technology flow and process flow.

JD.com

Venture Round in 2018
JD.com is a leading online direct sales company in China, renowned for its extensive transaction volume and significant market share. The platform provides consumers with a diverse selection of authentic products at competitive prices, emphasizing a user-friendly online shopping experience through its website and mobile applications. To ensure timely and reliable delivery, JD.com has established a comprehensive nationwide fulfillment infrastructure, comprising numerous warehouses and a self-operated delivery network. This infrastructure allows the company to maintain high customer satisfaction levels and supports both its direct sales and online marketplace operations. JD.com also includes JD Health, an e-commerce platform for pharmaceutical products, and JD Logistics, which offers supply chain and logistics services, including innovative solutions like drone deliveries. With a strong emphasis on technology, JD.com has invested in a proprietary platform to facilitate growth and enhance service offerings, employing a substantial workforce to support its operations across China.

United Imaging Healthcare

Series A in 2017
United Imaging Healthcare develops and manufactures medical equipment and solutions. Its solutions cover areas of diagnostics, radiotherapy, and healthcare information technology solutions. United Imaging Healthcare offers medical imaging products such as computed tomography, molecular imaging, magnetic resonance, and X-ray radiography products, radiotherapy equipment, and uCloud UIH Intelligent Medical Cloud, a medical cloud platform for medical resource sharing and mass diagnostic data mining. It also provides customer, technical support, dispatching, and training services. United Imaging Healthcare began operation in 2011, with its headquarters in Shanghai in China. It has locations in Concord, Cleveland, Houston, Wuhan, and Shenzhen.

Gu Sheng Tang

Series D in 2017
Gu Sheng Tang (GST) is a China-based healthcare services provider that operates a chain of private clinics specializing in traditional Chinese medicine.

Didi

Debt Financing in 2016
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi-hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation.

Didi

Funding Round in 2016
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi-hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation.

Uber

Series B in 2016
Uber connects riders with safe, reliable, and convenient transportation providers at a variety of price points in cities around the world. Uber's China unit was acquired by Didi Chuxing in August 2016 after being valued at $7 billion (pre-money) earlier in the year.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.